Clinical Trial Update: The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V) [Phase 2]

View source ↗

Summary

Phase 2 trial examining the effects of triheptanoin in adults with McArdle disease (Glycogen Storage Disease Type V) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Glycogen Storage Disease Type V | Phase 2 | Status: COMPLETED